Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 29,326 shares at $28.01 ($825K) on 2021-08-30, disclosed to the SEC on 2021-08-31.
Open-market sale of $825k ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.17 | 8,248 | $232K | 28.2% |
| 2 | $28.17 | 8,248 | $232K | 28.2% |
| 3 | $28.01 | 2,322 | $65K | 7.9% |
| 4 | $28.01 | 2,322 | $65K | 7.9% |
| 5 | $28.12 | 4,093 | $115K | 14.0% |
| 6 | $28.12 | 4,093 |
| $115K |
| 14.0% |
| Total | $28.13 avg | 29,326 | $825K | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |